Giovanni Paolino, MD

Article

Skin Lesions in Patients Treated With Imatinib Mesylate: A 5-Year Prospective Study

Author:: Giovanni Paolino, MD

Publish date: June 7, 2016

Imatinib mesylate (IM) represents the first-line treatment of patients with chronic myeloid leukemia (CLM) or gastrointestinal stromal tumor (GIST)...